Skip to content

Deep Learning Reconstruction Algorithms in Dual Low-dose CTA

Evaluation of Deep Learning Reconstruction Algorithms in Dual Low-dose CT Vascular Imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06372756
Enrollment
1200
Registered
2024-04-18
Start date
2023-06-01
Completion date
2026-03-31
Last updated
2024-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Learning

Brief summary

The goal of this observational study is to evaluate the impact of deep learning image reconstruction on the image quality and diagnostic performance of double low-dose CTA. The main question it aims to answer is to explore the feasibility of deep learning image reconstruction in double low-dose CTA.

Detailed description

1. The raw data from patients who underwent head and neck CTA, coronary CTA, and abdominal CTA in both standard dose and double low-dose groups were included. 2. Techniques such as filtered back projection, iterative reconstruction, and deep learning reconstruction were performed. 3. The feasibility of deep learning reconstruction in double low-dose CTA was evaluated based on image quality and diagnostic performance.

Interventions

DIAGNOSTIC_TESTDeep learning image reconstruction

Deep learning image reconstruction (DLIR) is a newly developed artificial intelligence noise reduction algorithm in recent years. It trains massive high-quality FBP data sets to learn to distinguish noise and signal, so as to selectively reduce noise and reconstruct high-quality images with low-quality image data.

Sponsors

Hao Tang
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with head and neck CTA, coronary artery CTA, and abdominal CTA due to stroke, coronary heart disease and abdominal inflammatory disease, and abdominal tumors.

Exclusion criteria

* Age \<18 years, pregnancy, allergic reaction to iodine contrast agent, renal insufficiency, and severe hyperthyroidism.

Design outcomes

Primary

MeasureTime frameDescription
The specificity and sensitivity calculated through the optimal cutoff value of the receiver operating characteristic curve.2026.1The specificity and sensitivity were calculated separately for the standard dose group and the double low-dose group using the optimal cutoff value from the receiver operating characteristic curve, for the purpose of comparing diagnostic accuracy between the two groups.

Secondary

MeasureTime frameDescription
The signal-to-noise ratio calculated from image CT values and noise2026.1The signal-to-noise ratio was calculated separately for the standard dose group and the double low-dose group using image CT values and noise, to assess the image quality between the two groups.

Countries

China

Contacts

Primary ContactYoufa M Tang, Doctor
1525573397@qq.com8613554101223
Backup ContactTan, Doctor
1655118783@qq.com86 159 2631 4149

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026